MedTrace Logo

Hypoglycemia and Autonomic Nervous System Function

NCT01816893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-04-02

Study results available
· View outcomes & findings →

Summary

The goals of this proposal are to determine the effects of hypoglycemia on the autonomic nervous system.

Conditions

Interventions

OTHER

Hypoglycemic hyperinsulinemic clamp

OTHER

Euglycemic hyperinsulinemic clamp

Sponsors & Collaborators

  • Beth Israel Deaconess Medical Center

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Gail K Adler, MD, PhD · Brigham and Women's Hospital

  • Roy L Freeman, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-08
Primary Completion
2007-11-06
Completion
2007-11-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01816893 on ClinicalTrials.gov